摘要
用自制的生物导向显像剂１３１Ｉ—ＳＺ３９静脉注射于４０例经Ｘ—ＣＴ证实的颅内占位患者，ＳＰＥＣＴ扫描出现阳性免疫复合物时，在占位区域内呈现红色斑块，藉此对胶质瘤进行定性诊断，并与Ｘ－ＣＴ进行对比．分析其定性诊断效能。结果其敏感性９２％，正确性８２％，阳性预报价值８１％，阴性预报价值９１％。明显优于Ｘ－ＣＴ。
patients with X-CT confirmed intracranial space occupying di- seases were intravenously injected with the targeting image agent 131 I-SZ39 pepared in our laboratory. With SPECT scanning, the positive complex will display a red colour in the space occupying area which confirms the diagnosis of glioma. The differential diag- nosis efficiency of SPECT targeting diagnosis was also compared with that of X-CT. The result showed that the sensitivity rate is 92%, the accurate rate 82%, the positive predication rate 81 %, and the negative predication rate 91 %, indicating that the targe- ting diagnosis with SPECT is much more reliable than X-CT.
出处
《癌症》
SCIE
CAS
CSCD
北大核心
1995年第4期271-273,共3页
Chinese Journal of Cancer
基金
本研究为工业"八.五"攻关课题已通过部级鉴定。
关键词
脑肿瘤
生物导向
影像学诊断
胶质瘤
CT
Brain tumor Monoclonal antibody Radioactive isotope Image diagnosis
